# Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anti-tnf-antibody-therapy-in-rheumatoid-arthritis-and-the-risk-of-serious/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tim Bongartz,Alex J. Sutton,Michael Sweeting,Iain Buchan,Eric L. Matteson,Víctor M. Montori |
| Citations | 2,479 |
| DOI | 10.1001/jama.295.19.2275 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2131882149 |
| PMID | 16705109 |
| Type | article |
| Year | 2006 |

## Paper authors

- [Eric L. Matteson](https://scholariq.org/researchers/eric-l-matteson/)

## Paper journal

- [JAMA](https://scholariq.org/journals/jama/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.